Related Experiment Video

Updated: Jun 24, 2026

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

Pontocerebellar hypoplasia type III (CLAM): extended phenotype and novel molecular findings

Burak Durmaz1, Bernd Wollnik, Ozgur Cogulu

  • 1Ege University, Faculty of Medicine, Dept. of Pediatrics, Divison of Genetics, 35100, Bornova, Izmir, Turkey. burak.durmaz@ege.edu.tr

Journal of Neurology
|March 12, 2009
PubMed

Insights

This study details a second family with cerebellar atrophy with progressive microcephaly (CLAM), a rare pontocerebellar hypoplasia disorder. Researchers narrowed the critical genetic region, aiding future gene identification for this neurodevelopmental condition.

Area of Science:

  • Neuroscience
  • Genetics
  • Developmental Biology

Background:

  • Pontocerebellar hypoplasia (PCH) encompasses a spectrum of neurodevelopmental disorders.
  • Cerebellar atrophy with progressive microcephaly (CLAM) is a recently identified, rare PCH subtype.

Observation:

  • A second family with CLAM presented with severe developmental delay, microcephaly, short stature, and cerebellar, brainstem, and cerebral hypoplasia.
  • Additional features included corpus callosum hypoplasia, hearing loss, optic atrophy, and epilepsy with posterior foci.
  • Molecular analysis identified a homozygous haplotype, significantly narrowing the critical region for the causative gene.

Findings:

  • The critical region for CLAM was reduced from 20 Mb to 7 Mb.
  • Candidate genes CROT and SLC25A40 within the narrowed region were sequenced, but no causative mutations were found.
  • This case expands the known clinical spectrum of CLAM.

Implications:

  • Further systematic positional cloning efforts are warranted to identify the gene responsible for CLAM.
  • Understanding the genetic basis of CLAM will improve diagnosis and potential therapeutic strategies for PCH disorders.
  • This research contributes to the broader understanding of cerebellar development and associated neurodevelopmental conditions.

More Related Videos

Three-Dimensional Cephalometric Landmark Annotation Demonstration on Human Cone Beam Computed Tomography Scans10:23

Three-Dimensional Cephalometric Landmark Annotation Demonstration on Human Cone Beam Computed Tomography Scans

Published on: September 8, 2023

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...